Secondary Logo

Journal Logo

Erratum

Efficacy and Safety of Intense Pulsed Light in Patients With Meibomian Gland Dysfunction—A Randomized, Double-Masked, Sham-Controlled Clinical Trial: Erratum

doi: 10.1097/ICO.0000000000002341
  • Free

In the article “Efficacy and Safety of Intense Pulsed Light in Patients With Meibomian Gland Dysfunction—A Randomized, Double-Masked, Sham-Controlled Clinical Trial,” published on pages 325–332 of the March 2020 issue of Cornea, the funding statement appeared as follows:

“This study was primarily supported by the 90th Anniversary of Chulalongkorn University Fund (Ratchadaphiseksomphot Endowment Fund) and Ratchadapiseksompotch Fund, Faculty of Medicine, Chulalongkorn University. The funding has no role in conducting this research.”

The authors would like to correct the funding statement to include to provide expanded names of some of the funding bodies and funds. The correct statement should read:

“This study was primarily supported by the 90 Anniversary of Chulalongkorn University Fund (Ratchadaphiseksomphot Endowment Fund), his Majesty the King Bhumibol Adulyadej's 72nd Birthday Anniversary Scholarship from the Graduate School, Chulalongkorn University and Ratchadapiseksompotch Fund, Faculty of Medicine, Chulalongkorn University. The funding has no role in conducting this research.”

REFERENCE

1. Piyacomn Y, Kasetsuwan N, Reinprayoon U, et al. Efficacy and safety of intense pulsed light in patients with meibomian gland dysfunction—a randomized, double-masked, sham-controlled clinical trial. Cornea. 2020;39:325–332.
    Copyright © 2020 Wolters Kluwer Health, Inc. All rights reserved.